about
Fibroblast growth factor signaling in skeletal development and diseaseVitamin D deficiency in India: prevalence, causalities and interventionsUpdate review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus.Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
FGF23 associated bone diseases.
@en
type
label
FGF23 associated bone diseases.
@en
prefLabel
FGF23 associated bone diseases.
@en
P2860
P1476
FGF23 associated bone diseases.
@en
P2093
Eryuan Liao
P2860
P2888
P356
10.1007/S11684-013-0254-6
P577
2013-03-09T00:00:00Z
P6179
1049766450